Maia Biotechnology, Inc.
Chicago, IL
- UEI
- NPLUZJSWA853
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 950 N Clark St k, Chicago, IL 60610, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel telomere-targeting therapy for advanced non-small cell lung cancer | National Cancer Institute (NIH) | $770,168 |
Quick answers
Is Maia Biotechnology, Inc. registered in SAM.gov?
Yes. Maia Biotechnology, Inc.'s SAM.gov registration is active through December 15, 2026.
What is Maia Biotechnology, Inc.'s most recent federal award?
Maia Biotechnology, Inc.'s most recent federal grant award is Novel telomere-targeting therapy for advanced non-small cell lung cancer (R44CA309843), from National Cancer Institute (NIH), on September 9, 2025.
On GovTribe
See Maia Biotechnology, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors